Ambulero Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
Ambulero General Information
Description
Operator of a biotechnology company intended to develop new ways to treat vascular tissue disease. The company specializes in developing cell and gene therapy products and delivering the adhesion molecule using different cell and synthetic vector technologies, enabling healthcare professionals to help heal damaged limbs significantly better than sham controls.
Contact Information
Website
www.ambulero.comCorporate Office
- 1951 Northwest 7th Avenue
- Suite 600
- Miami, FL 33136
- United States
Corporate Office
- 1951 Northwest 7th Avenue
- Suite 600
- Miami, FL 33136
- United States
Ambulero Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 13-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | Cancelled | Pre-Clinical Trials | ||||
| 2. Corporate | 25-Jan-2021 | $5.5M | $5.5M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Ambulero Signals
Ambulero Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endless Frontier Labs | Accelerator/Incubator | |||
| Orphinic Scientific | VC-Backed Company | Minority | ||
| Ventac Partners | Venture Capital | Minority | ||
| University of Miami | University |
Ambulero FAQs
-
When was Ambulero founded?
Ambulero was founded in 2019.
-
Where is Ambulero headquartered?
Ambulero is headquartered in Miami, FL.
-
What is the size of Ambulero?
Ambulero has 3 total employees.
-
What industry is Ambulero in?
Ambulero’s primary industry is Drug Discovery.
-
Is Ambulero a private or public company?
Ambulero is a Private company.
-
What is Ambulero’s current revenue?
The current revenue for Ambulero is .
-
How much funding has Ambulero raised over time?
Ambulero has raised $5.5M.
-
Who are Ambulero’s investors?
Endless Frontier Labs, Orphinic Scientific, Ventac Partners, and University of Miami have invested in Ambulero.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process